Measuring patients' priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks [0.03%]
基于层次分析法与最佳最差评分法和打分卡的患者优先级测量：方法学及排序任务
Katharina Schmidt,Ana Babac,Frédéric Pauer et al.
Katharina Schmidt et al.
Background: Identifying patient priorities and preference measurements have gained importance as patients claim a more active role in health care decision making. Due to the variety of existing methods, it is challenging ...
Design and implementation of community engagement interventions towards healthcare quality improvement in Ghana: a methodological approach [0.03%]
走向质量改进的社区参与干预措施的设计与实现——以加纳为例
Robert Kaba Alhassan,Edward Nketiah-Amponsah,Daniel Kojo Arhinful
Robert Kaba Alhassan
Background: Nearly four decades after the Alma-Ata declaration of 1978 on the need for active client/community participation in healthcare, not much has been achieved in this regard particularly in resource constrained co...
Saturnin Bertrand Nguenda Anya,Atanase Yene
Saturnin Bertrand Nguenda Anya
This paper seeks to identify the determinants of the choice of treatment of pregnant women in Cameroon. Theoretically, the methodology is based on a discrete choice model with random utility. Empirically, the econometric specification is a ...
Erratum to: Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia [0.03%]
对“淋巴水肿治疗强制要求的成本——弗吉尼亚州十年来的经验”的勘误
Robert Weiss
Robert Weiss
Published Erratum
Health economics review. 2016 Dec;6(1):47. DOI:10.1186/s13561-016-0125-3 2016
Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany - are additional data requirements by the Federal Joint Committee justified? [0.03%]
德国监管机构的药物警戒措施与透明化倡议机构的证据要求之间的比较——联邦联合委员会的额外数据要求合理吗？
Jörg Ruof,Thomas Staab,Charalabos-Markos Dintsios et al.
Jörg Ruof et al.
Objectives: The aim of this study was to compare post-authorisation measures (PAMs) from the European Medicines Agency (EMA) with data requests in fixed-termed conditional appraisals of early benefit assessments from the ...
Health expenditures spent for prevention, economic performance, and social welfare [0.03%]
预防性卫生支出、经济绩效及社会福利的关系研究
Fuhmei Wang,Jung-Der Wang,Yu-Xiu Huang
Fuhmei Wang
Background: Countries with limited resources in economic downturns often reduce government expenditures, of which spending on preventive healthcare with no apparent immediate health impact might be cut down first. This re...
Heterogeneity in general practitioners' preferences for quality improvement programs: a choice experiment and policy simulation in France [0.03%]
法国基层医生质量改进项目的异质性偏好：选择实验与政策模拟研究
Mehdi Ammi,Christine Peyron
Mehdi Ammi
Despite increasing popularity, quality improvement programs (QIP) have had modest and variable impacts on enhancing the quality of physician practice. We investigate the heterogeneity of physicians' preferences as a potential explanation of...
Utilization of healthcare services and renewal of health insurance membership: evidence of adverse selection in Ghana [0.03%]
利用医疗服务和续订健康保险会员资格：加纳的逆向选择证据
Stephen Kwasi Opoku Duku,Francis Asenso-Boadi,Edward Nketiah-Amponsah et al.
Stephen Kwasi Opoku Duku et al.
Background: Utilization of healthcare in Ghana's novel National Health Insurance Scheme (NHIS) has been increasing since inception with associated high claims bill which threatens the scheme's financial sustainability. Th...
Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia [0.03%]
Virginia十年淋巴水肿治疗强制的经验教训的成本分析
Robert Weiss
Robert Weiss
Treatment of chronic illness accounts for over 90 % of Medicare spending. Chronic lymphedema places over 3 million Americans at risk of recurrent cellulitis. Health insurers and legislators have taken an active role in fighting attempts to ...
Erratum to: 'Quality of life and costs of spasticity treatment in German stroke patients' [0.03%]
german卒中患者痉挛治疗的生活质量和费用的更正通知
Reinhard Rychlik,Fabian Kreimendahl,Nicole Schnur et al.
Reinhard Rychlik et al.
Published Erratum
Health economics review. 2016 Dec;6(1):41. DOI:10.1186/s13561-016-0114-6 2016